Conflict-of-interest policies for investigators in clinical trials.
about
Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research.Does pharmaceutical advertising affect journal publication about dietary supplements?Integrating bioethics into clinical and translational science research: a roadmap.Oversight of financial conflicts of interest in commercially sponsored research in academic and nonacademic settingsDancing with the porcupine: rules for governing the university-industry relationshipKey personnel and "long distance" settings: determining who must report financial conflict of interest.Streamlining the clinical research enterprise.Review article: gastroenterology and the pharmaceutical industry.Current issues in clinical research and the development of new pharmaceuticals.Conflict of interest in clinical research.Ethical issues in molecular medicine of relevance to surgeons.Potential research participants' views regarding researcher and institutional financial conflicts of interestPublication of clinical trials: accountability and accessibility.The complexities of individual financial conflicts of interest.Institutional conflicts of interest: protecting human subjects, scientific integrity, and institutional accountability.Benchmarks for ethically credible partnerships between industry and academic health centers: beyond disclosure of financial conflicts of interest.Academic-industrial collaboration: the good, the bad, and the ugly.Institutional Conflict of Interest Policies at U.S. Academic Research Institutions.Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.Ethical attitudes of nurse, physician, and unaffiliated members of institutional review boards.Comparison of conflict of interest policies and reported practices in academic medical centers in the United States.High technology in medicine: lessons from cardiovascular innovations and future perspective.Conduct, Oversight, and Ethical Considerations of Clinical Trials in Companion Animals with Cancer: Report of a Workshop on Best Practice Recommendations.Community hospital oversight of clinical investigators' financial relationships.Conflicts of interest in biomedical publications: considerations for authors, peer reviewers, and editors.Overseeing innovative therapy without mistaking it for research: a function-based model based on old truths, new capacities, and lessons from stem cells.Replication in prevention science.An innovative strategy for conducting clinical research: the academic associate program.Current ethical issues in HIV/AIDS research and HIV/AIDS care.Managing conflict of interest in research: some suggestions for investigators.The human subjects trade: ethical and legal issues surrounding recruitment incentives.Ethics and the pharmaceutical industry.Ethical issues in health research in childrenPerceptions of Research Ethics Practices: IntegratedEthics™ Staff Survey Data from the VA Health Care System
P2860
Q30433010-4640D067-FB59-4BB6-9414-BEDF273D1752Q30438344-06D46353-F371-47DA-9EE0-2C4B89B9450EQ33327425-49E08220-F666-4219-9396-2A604B576C86Q33712724-A245B108-59CD-438E-837E-B9585EE92433Q33790942-44B4EBBA-44E5-4D54-9268-B8308A9F9015Q33956540-1C158B57-02A0-4EF0-AD16-518F709C6134Q34044626-D887505C-2976-4909-A59A-4FEDD0654DA7Q34846843-4DD5CA7C-35BE-41B9-8967-908E11C11A56Q34975839-3D633821-E7CA-4A2C-87C4-6093F1EABE76Q35025550-2F09533D-5F50-4442-9DE0-07133EB7ECD9Q35041593-DFA0CD90-5155-4F98-9F15-7B3697DEC721Q35537370-140A7027-09E5-4A1F-94F6-47DD9112C528Q35559571-A6260E21-B3FD-4E72-A49D-591F445711DBQ35887485-19649E37-3A36-4A7D-AA2D-074606BE35A1Q35911450-706AE716-78DD-4CE3-9A69-66B8CEC1DA9EQ36088088-75722327-754C-4965-9BC6-D79C99DF1F19Q36369216-67F4059C-D835-46CA-B2F7-5A915B1EB7B0Q36372361-CE4B513C-38C2-40A5-BD4D-A7D6AB0235FFQ36515317-A9342C1E-185F-4D1F-8D85-8463AFF2D0D7Q36697796-F8678C8F-4A48-40DE-BDE4-E1236C4FBCDAQ36773946-C041D166-4446-4693-BC29-3B63D779EFEFQ36775514-F2002B6C-EC29-4EF2-9063-F9B8D65068CBQ36919252-24C49807-BECE-4E59-9050-3A6D272027DCQ37020305-0CF7647A-EC30-473F-BFD7-3B13C91029D7Q37142889-FEA75AF4-212F-44BF-8860-DFA08718FCEFQ37487299-7F985595-0E3A-4B3F-908A-A6A2C3261806Q37767769-0245D00C-46DE-4F13-8E67-A7E3EFD31471Q37871900-B83223F2-5D4B-4779-BFC1-BF02F0AA7810Q38469380-E560DDBE-9C80-448B-9ADA-7CEC7B64CD18Q38816192-0124A515-EE28-4CFF-B7A0-EE924038F5C0Q48430353-8C40F588-21C1-4AB4-AA3E-FF0110882360Q48571469-572C1D90-A170-4E1A-99F6-B7F2EE43276DQ50630795-9507A4A2-D75F-4716-A279-578CE2FBECC8Q56783697-BDFFB874-E4E6-410A-A2C3-915DF494E6E5Q58250189-969FDADF-1F5F-4D51-8E0A-DB7190DC44CC
P2860
Conflict-of-interest policies for investigators in clinical trials.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Conflict-of-interest policies for investigators in clinical trials.
@ast
Conflict-of-interest policies for investigators in clinical trials.
@en
Conflict-of-interest policies for investigators in clinical trials.
@nl
type
label
Conflict-of-interest policies for investigators in clinical trials.
@ast
Conflict-of-interest policies for investigators in clinical trials.
@en
Conflict-of-interest policies for investigators in clinical trials.
@nl
prefLabel
Conflict-of-interest policies for investigators in clinical trials.
@ast
Conflict-of-interest policies for investigators in clinical trials.
@en
Conflict-of-interest policies for investigators in clinical trials.
@nl
P2093
P1476
Conflict-of-interest policies for investigators in clinical trials.
@en
P2093
P304
P356
10.1056/NEJM200011303432206
P407
P577
2000-11-01T00:00:00Z